Menstrual cycle effects on urinary estrogen metabolites

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 11, 1999, Pages 3914-3918

  Xu, Xia ^a   Duncan, Alison M ^a   Merz Demlow, Barbara E ^a   Phipps, William R ^b   Kurzer, Mindy S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA HYDROXYESTRONE; 4 HYDROXYESTRADIOL; ESTRADIOL; ESTROGEN; ESTRONE; ESTRONE DERIVATIVE;

ARTICLE; CAPILLARY GAS CHROMATOGRAPHY; ESTROGEN METABOLISM; FEMALE; HUMAN; ION EXCHANGE CHROMATOGRAPHY; MASS SPECTROMETRY; MENSTRUAL CYCLE; NORMAL HUMAN; PRIORITY JOURNAL; URINE LEVEL;

EID: 0033310865     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.11.3914     Document Type: Article

References (43)

1. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer
2. A prospective study of endogenous estrogens and breast cancer in post-menopausal women
3. A prospective study of urinary oestrogen excretion and breast cancer risk
4. Estrogens as a cause of human cancer: The Richard and Hinda Rosenthal Foundation Award Lecture
5. The role of estrogen in mammary carcinogenesis
6. Estrogen metabolites as bioreactive modulators of tumor initiators and promoters
7. Molecular mechanisms of estrogen carcinogenesis
8. Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators
9. Medical progress: Endometrial carcinoma
10. Induction by estrogen metabolite 16α-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells
11. Biological properties of 16α-hydroxyestrone: Implications in estrogen physiology and pathophysiology
12. Covalent binding of the endogenous estrogen 16α-hydroxyestrone to estradiol receptor in human breast cancer cells: Characterization and intranuclear localization
13. 16α-Hydroxylation of estradiol: A possible risk marker for breast cancer
14. Abnormal oxidative metabolism of estradiol in women with breast cancer
15. Increased estrogen-16α- hydroxylase activity in women with breast and endometrial cancer
16. Urinary estrogen metabolites and breast cancer: A case-control study
17. Urinary 2/16α-hydroxyestrone ratio: Correlation with serum insuline-like growth factor binding protein-3 and a potential biomarker of breast cancer risk
18. Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up
19. Urinary 2-hydroxyestrone/16α-hydroxyestrone ratio and risk of breast cancer in postmenopausal women
20. Kinetics of catecholestrogen-estrogen receptor dissociation: A possible factor underlying differences in catecholestrogen biological activity
21. Binding of 2-hydroxyestradiol and 4- hydroxyestradiol to estrogen receptors from human breast cancers
22. Catecholestrogens are MCF-7 cell estrogen agonists
23. DNA single strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens. Hormone-induced free radical damage preceding renal malignancy
24. 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: Role of free radicals in estrogen-induced carcinogenesis
25. 4-Hydroxylation of estrogens as marker of human mammary tumors
26. Estrogen metabolism and excretion in oriental and caucasian women
27. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women
28. Urinary excretion of catecholestrogens, 2-methoxyestrogens and 'classical estrogens' throughout the normal menstrual cycle
29. Measurement of urinary estrogen metabolites using a monoclonal enzyme-linked immunoassay kit: Assay performance and feasibility for epideminological studies
30. Soy isoflavones exert modest hormonal effects in premenopausal women
31. Body fat assessed from total body density and its estimation from skinfold thickness: Measurement on 481 men and women aged 16 to 72 years
32. The multicomponent analysis of estrogens in urine by ion exchange chromatography and GC-MS-I. Quantitation of estrogens after initial hydrolysis of conjugates
33. Deuterium labelled ethoximes as stable isotope internal standards in the GC-MS-SIM determination of oxo-estrogens in human urine extracts: Preliminiary results
34. Isotope dilution gas chromatographic-mass spectrometric method for the determination of lignans and isoflavonoids in human urine, inclusing identification of genistein
35. Quantifying estrogen metabolism: An evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16α-hydroxyestronein urine
36. Gender effects in pharmacokinetics and pharmacodynamics
37. Sex-related differences in drug disposition in man
38. Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics
39. Increased theophylline metabolism in the menstrual phase of healthy women
40. Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone
41. Estradiol metabolism by complementary deoxyribonucleic acid-expressed human cytochrome P450s
42. Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes
43. Induction and inhibition of estradiol hydroxylase activities in MCF-7 human breast cancer cells in culture